IPO Listed — 17 Dec 2025

Listing Price: ₹158.80 (-1.98% vs ₹162)

View GMP History →

IPO Details GMP Review

More sections

Other pages for this IPO

Subscription Allotment

Park Medi World IPO Review

Q: What was the actual listing price of Park Medi World IPO?

Park Medi World IPO listed on December 17, 2025 at ₹158.80, against the issue price of ₹162 — a loss of -1.98% (₹3.2 per share).

Q: What is the price band and lot size of Park Medi World IPO?

Park Medi World IPO is priced at ₹154 – 162 per share. The minimum lot size is 92 shares, making the minimum investment approximately ₹14,168 at the upper end of the price band. Subscription ran from 10 Dec 2025 to 12 Dec 2025.

Park Medi World IPO has been reviewed by 14 analysts, and the overall consensus is Strong Apply — carrying a score of 85. Out of the 14 analysts who have covered this IPO, 10 recommend subscribing while 4 advise caution or avoidance — reflecting a mixed view from the analyst community.

The issue is priced in the band of ₹154 – 162 per share , with a minimum application size of 92 shares (minimum investment of approximately ₹14,168 at the upper band) . Subscription ran from 10 Dec 2025 to 12 Dec 2025. Scroll down for the full analyst breakdown and analyst-wise verdicts.

General Review

Park Medi World Ltd. operates one of North India’s largest private hospital chains with 14 multi-specialty hospitals.
Its IPO was open from 10–12 Dec 2025 with a price band of ₹154–₹162 and a ₹920 Cr issue size.
The offer comprised a fresh issue (₹770 Cr) and an OFS (₹150 Cr), and saw strong subscription interest (~8.1×).
Post-IPO, promoter shareholding is expected to reduce from ~95.55% to ~82.89%

Listing Gains

At the ₹162 upper band the notes value the issue at about 29.2 times FY25 earnings on trailing EPS of ₹5.5, with EV to sales of 4.6 times. Analysts consider that reasonable for a hospital network, and ten of nineteen said subscribe with three neutral.

Short Term Strategy

Operating margin improved sharply to 23.16 percent in the half year to September 2025, from 10.73 percent in FY25, with EBITDA of ₹110.31 crore on ₹483.97 crore of revenue. Newer hospitals adding about 1,650 beds now contribute over half of revenue and profit, which drove that improvement.

Long Term Strategy

The long-term case rests on the maturing bed base. Hospitals take years to reach full occupancy, and the notes point out the recently added capacity is already carrying more than half of earnings. Continued expansion plus rising occupancy at existing units is what the subscribe ratings assume.

Disclaimer: This review is an AI summary derived from the reviews of all analysts.

Analyst Verdict & Score
Detailed Review
Analyst Reviews
Frequently Asked Questions

Analyst Sentiment

Analytical Score

How it's calculated?

Strong Apply

85 / 100

Recommend Subscribe

Based on 14 analyst reviews

10 / 14

Higher consensus indicates broader analyst agreement.

Analyst Review

Analyst	Verdict	View
Nirmal Bang	Apply
Canara Bank Securities	May apply
Anand Rathi	Apply
BP Equities	Apply
GEPL Capital	Apply
Choice equity broking	Apply
SBI Securities	Neutral
Sushil Finance	Apply
Lakshmishree Investment	Apply
Capital Market	Neutral
Swastika Investmart	Apply
Kunvarji Wealth	Apply
Stoxbox	Apply
SMC Global	Neutral
Axis Capital	Not rated
Bajaj finance pvt ltd	Not Rated
Dilip Davda	Not rated	-
JM Financial	Not rated
Systematix secrities ltd	Not rated

Latest IPO Reviews

Manika Plastech Strong Apply

Score

Veegaland Developers Apply

Score

Rentomojo Apply

Score

Asset Reconstruction Co.(India) Strong Apply

Score

Frequently Asked Questions

Should I apply for Park Medi World IPO?

Based on analyst coverage tracked on this page, the overall verdict for Park Medi World IPO is Strong Apply. Out of 14 analysts who have reviewed this IPO, 10 recommend subscribing. Always cross-check with the full analyst reviews below and consult a SEBI-registered advisor before making any investment decision.

What does the score of 85 mean for Park Medi World IPO?

The score of 85 is an aggregate of all analyst ratings tracked for Park Medi World IPO. A score in this range indicates strong analyst confidence — most analysts are recommending a subscribe. Scroll down to read individual analyst verdicts for more context.

What was the actual listing price of Park Medi World IPO?

Park Medi World IPO listed on December 17, 2025 at ₹158.80 , against the issue price of ₹162 — a loss of -1.98% (₹3.2 per share). View the full GMP history page for day-wise pre-listing trends.

What is the price band and lot size of Park Medi World IPO?

Park Medi World IPO was priced at ₹154 – 162 per share. The minimum lot size is 92 shares, making the minimum investment approximately ₹14,168 at the upper end of the price band. Subscription ran from 10 Dec 2025 to 12 Dec 2025.

Explore Park Medi World IPO Further

Track every stage of this IPO:

📈

GMP Today

Live grey market premium

📊

Subscription Status

Real-time bidding data

📋

Allotment Status

Check if you got shares

Disclaimer: Grey Market Premium (GMP) is for information purposes and is not a guarantee of listing price. Always consult your financial advisor before investing.